GSK

1,858.5

-0.83%↓

GSK

1,858.5

-0.83%↓

GSK

1,858.5

-0.83%↓

GSK

1,858.5

-0.83%↓

GSK

1,858.5

-0.83%↓

Search

Haleon PLC

Uždarymo kaina

SektoriusSveikatos priežiūra

343.7 1.06

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

341.1

Max

343.8

Pagrindiniai rodikliai

By Trading Economics

Pajamos

403M

Pardavimai

2.7B

P/E

Sektoriaus vid.

17.216

51.415

Pelnas, tenkantis vienai akcijai

0.044

Dividendų pajamingumas

2.14

Pelno marža

14.708

Darbuotojai

24,535

EBITDA

697M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+29.65% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

2.14%

2.34%

Kitas uždarbis

2026-07-30

Kita Ex Dividend data

2026-08-13

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

29B

Ankstesnė atidarymo kaina

342.64

Ankstesnė uždarymo kaina

343.7

Naujienos nuotaikos

By Acuity

46%

54%

144 / 345 reitingas Healthcare

Haleon PLC Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-04-29 07:48; UTC

Uždarbis

Sensodyne-Maker Haleon Revenue Rises on Oral Health Growth -- Update

2026-04-29 06:39; UTC

Uždarbis

Sensodyne-maker Haleon Revenue Rises on Oral Health Growth

2026-02-25 07:55; UTC

Uždarbis

Panadol Maker Haleon Reports Revenue Slowdown Amid Weak Cold-And-Flu Season

2026-04-29 08:05; UTC

Rinkos pokalbiai
Uždarbis

Haleon's North America Results Were Encouraging -- Market Talk

2026-04-29 07:46; UTC

Rinkos pokalbiai
Uždarbis

Haleon's First-Quarter Results Align With Peers -- Market Talk

2026-04-29 06:07; UTC

Uždarbis

Haleon: 1Q Emerging Markets Revenue Growth 4.3%

2026-04-29 06:06; UTC

Uždarbis

Haleon: Q1 North America Organic Revenue Growth 1.0%

2026-04-29 06:05; UTC

Uždarbis

Haleon 1Q Reported Revenue Growth 0.1%

2026-04-29 06:04; UTC

Uždarbis

Analysts Saw Haleon 1Q Organic Revenue Growth 2.3%

2026-04-29 06:04; UTC

Uždarbis

Haleon 1Q Organic Revenue Growth 2.2%

2026-04-29 06:04; UTC

Uždarbis

Haleon 1Q Rev GBP2.86B

2026-04-29 06:04; UTC

Uždarbis

Haleon Sees High-single Digit Adjusted Operating Profit Growth at Constant Currency in Medium Term

2026-04-29 06:03; UTC

Uždarbis

Haleon Sees 4% to 6% Organic Rev Growth in Medium Term

2026-04-29 06:03; UTC

Uždarbis

Haleon Expects a Broadly Neutral Foreign Exchange Translation Impact on Net Rev, Adj Oper Pft

2026-04-29 06:02; UTC

Uždarbis

Haleon Sees 2026 Adjusted Effective Tax Rate c.24.5%

2026-04-29 06:02; UTC

Uždarbis

Haleon: Sees 2026 Net Interest GBP255 Million

2026-04-29 06:02; UTC

Uždarbis

Haleon Sees 2026 High-single Digit Adj Oper Pft Growth at Constant Currency

2026-04-29 06:01; UTC

Uždarbis

Haleon Sees 2026 Organic Revenue Growth 3% to 5%

2026-02-25 07:18; UTC

Uždarbis

Haleon 4Q Organic Revenue Growth 2.1%

2026-02-25 07:17; UTC

Uždarbis

Haleon: GBP500M Allocated to Share Buybacks in 2026

2026-02-25 07:16; UTC

Uždarbis

Haleon Sees 2026 High Single Digit Adj. Operating Profit Growth at Constant Currency

2026-02-25 07:15; UTC

Uždarbis

Haleon Sees 2026 Organic Revenue Growth of 3% to 5%

2026-02-25 07:06; UTC

Uždarbis

Haleon Declares Final Dividend of 4.9p

2026-02-25 07:05; UTC

Uždarbis

Haleon 2025 Net Pft GBP1.67B

2026-02-25 07:05; UTC

Uždarbis

Haleon 2025 Pretax Pft GBP2.15B

2026-02-25 07:04; UTC

Uždarbis

Analysts Saw Haleon 2025 Adj Oper Pft at GBP2.46B

2026-02-25 07:04; UTC

Uždarbis

Analysts Saw Haleon 2025 Adj Oper Pft Margin at 22.3%

2026-02-25 07:04; UTC

Uždarbis

Analysts Saw Haleon 2025 Organic Revenue Growth at 3.4%

2026-02-25 07:04; UTC

Uždarbis

Analysts Saw Haleon 2025 Rev at GBP11.03B

2026-02-25 07:04; UTC

Uždarbis

Haleon 2025 Adj. Operating Pft Margin 22.9%

Akcijų palyginimas

Kainos pokytis

Haleon PLC Prognozė

Kainos tikslas

By TipRanks

29.65% į viršų

12 mėnesių prognozė

Vidutinis 426.67 GBX  29.65%

Aukščiausias 512 GBX

Žemiausias 325 GBX

Remiantis 10 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Haleon PLC kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

10 ratings

7

Pirkti

2

Laikyti

1

Parduoti

Rinkos nuotaikos

By Acuity

144 / 345 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Haleon PLC

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
help-icon Live chat